Loading clinical trials...
Loading clinical trials...
Patients with AECOPD and NIV failure and in absence will be treated with NHF device. Inclusion criteria are pH \< 7,38 and pCO2 \> 45 mm Hg. Patients were treated if pH \>7,38 or refusal of therapy.
Age
All ages
Sex
ALL
Healthy Volunteers
No
University of Leipzig
Leipzig, Germany
Start Date
May 15, 2018
Primary Completion Date
May 30, 2018
Completion Date
May 30, 2018
Last Updated
June 25, 2018
38
ACTUAL participants
Lead Sponsor
Jens Bräunlich, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions